Literature DB >> 11696641

Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol.

S Nikolaus1, R Larisch, M Beu, H Vosberg, H W Müller-Gärtner.   

Abstract

UNLABELLED: Several groups have developed high-resolution PET systems and shown the feasibility of in vivo studies on small laboratory animals. In this investigation, one of these systems was validated for the performance of receptor imaging studies. For this, the radiotracer concentrations obtained in the same animals with PET and with autoradiography were quantified, and the correspondence between both methods was assessed by means of correlation analysis.
METHODS: Striatal radioactivity was measured in 10 Sprague-Dawley rats after injection of 60 +/- 10 MBq of the dopamine D(2) receptor ligand (18)F-(N-methyl)benperidol in 6 time frames of 6 min each. On completion of the scans, animals were killed, and their brains were removed and sectioned using a cryostat microtome. Coronal slices were subjected to storage phosphor autoradiography with BaFBr:Eu(2+)-coated imaging plates. Striatal radioactivity was quantified in both modalities using region-of-interest analysis and activity standards.
RESULTS: After partial-volume correction, the median of striatal radioactivity concentration measured with PET was 0.40 MBq/cm(3) (25th percentile, 0.32; 75th percentile, 0.44). Radioactivity concentrations determined by means of storage phosphor autoradiography amounted to 0.42 MBq/cm(3) (25th percentile, 0.24; 75th percentile, 0.51). Correlation of striatal radioactivity values yielded a Pearson correlation coefficient of 0.818 (P = 0.002). Radioactivity accumulation in Harder's glands led to an overestimation of striatal activity concentrations by approximately 5%. The median of striatal radioactivity concentration after spillover correction decreased slightly to 0.38 MBq/cm(3) (25th percentile, 0.30; 75th percentile, 0.43). Correlation of striatal radioactivity values after spillover correction yielded a Pearson correlation coefficient of 0.824 (P = 0.002).
CONCLUSION: The results show a significant positive correlation between radioactivity values obtained with PET and storage phosphor autoradiography used as the gold standard. Because we applied a selective dopamine D(2) receptor radioligand and because radioactivity concentrations could be reliably quantified in the target region, we may infer that in vivo receptor binding studies will be possible in small laboratory animals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696641

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography.

Authors:  Elissa M Strome; Ivan L Cepeda; Vesna Sossi; Doris J Doudet
Journal:  Mol Imaging Biol       Date:  2006 Sep-Oct       Impact factor: 3.488

2.  Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.

Authors:  Susanne Nikolaus; Andreas Wirrwar; Christina Antke; Shahram Arkian; Nils Schramm; Hans-Wilhelm Müller; Rolf Larisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-12       Impact factor: 9.236

3.  Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.

Authors:  Goran Laćan; Alain Plenevaux; Daniel J Rubins; Baldwin M Way; Caroline Defraiteur; Christian Lemaire; Joel Aerts; André Luxen; Simon R Cherry; William P Melega
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-05       Impact factor: 9.236

4.  [123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT.

Authors:  Susanne Nikolaus; Rolf Larisch; Andreas Wirrwar; Marlyse Jamdjeu-Nouné; Christina Antke; Markus Beu; Nils Schramm; Hans-Wilhelm Müller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07-08       Impact factor: 9.236

5.  Development of a simultaneous PET/microdialysis method to identify the optimal dose of 11C-raclopride for small animal imaging.

Authors:  Wynne K Schiffer; David L Alexoff; Colleen Shea; Jean Logan; Stephen L Dewey
Journal:  J Neurosci Methods       Date:  2004-12-08       Impact factor: 2.390

6.  Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT.

Authors:  Susanne Nikolaus; Christina Antke; Markus Beu; Konstantin Kley; Andreas Wirrwar; Joseph P Huston; Hans-Wilhelm Müller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-26       Impact factor: 9.236

7.  Statistical parametric maps of ¹⁸F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation study.

Authors:  Elena Prieto; María Collantes; Mercedes Delgado; Carlos Juri; Luis García-García; Francisco Molinet; María E Fernández-Valle; Miguel A Pozo; Belén Gago; Josep M Martí-Climent; José A Obeso; Iván Peñuelas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-27       Impact factor: 9.236

8.  Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.

Authors:  Susanne Nikolaus; Rolf Larisch; Markus Beu; Farhad Forutan; Henning Vosberg; Hans-Wilhelm Müller-Gärtner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-17       Impact factor: 9.236

9.  Evaluation of inhibitory effect of recreational drugs on dopaminergic terminal neuron by PET and whole-body autoradiography.

Authors:  Skye Hsin-Hsien Yeh; Ming-Hsien Lin; Fan-Lin Kong; Chi-Wei Chang; Li-Chung Hwang; Chien-Feng Lin; Jeng-Jong Hwang; Ren-Shyan Liu
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.